This article discusses the author’s experience using ketamine therapy alongside cannabis and argues that the combination may be an unhealthy approach for managing depression and anxiety. It focuses on long-term effects, self-medication, and the challenges that can remain even when ketamine relieves depressive symptoms.
Ketamine Academy
English
17 days
This course page is a blog-style discussion of ketamine therapy and cannabis use, based on the author’s personal experience. It explores how ketamine may help relieve treatment-resistant depression while also describing the author’s view that cannabis did not remain a helpful companion treatment over time. The content addresses mental health management, self-medication, anxiety, depression, and the process of recognizing underlying behavioral and emotional patterns. It also reflects on the limits of ketamine as a treatment when broader recovery work is needed. This material is most relevant for people interested in ketamine therapy, depression recovery, and the interaction between ketamine and cannabis. It is presented as a narrative and reflective article rather than a formal training course.
People interested in ketamine therapy, depression recovery, anxiety management, and the interaction between ketamine and cannabis.
None stated.
Online certification training provider for healthcare professionals seeking to offer subanesthetic ketamine therapy. Offers two self-study course tracks — clinical-only and business-and-clinical — covering protocols, patient safety, consents, and business launch guidance for starting a ketamine clinic.
By Ketamine Academy
Spravato FastTrack is an implementation course for clinics that want to add Spravato (esketamine) services. It covers REMS certification, procurement, prior authorization, billing, documentation, and related operational steps.
By Double Blind
This article examines how ketamine clinics may serve as a model for future legal psychedelic therapy, especially for MDMA and psilocybin. It compares clinic models, regulation, and the role of psychotherapy in treatment delivery.
By CIIS
A 12-month certificate in psychedelic-assisted therapies and research offered by CIIS. The program includes hybrid or online study and covers clinical competencies, research, cultural context, and ethical practice.
Next cohort: Jun 1, 2026